SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-055874
Filing Date
2021-02-25
Accepted
2021-02-25 08:58:54
Documents
14
Period of Report
2021-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d100550d8k.htm   iXBRL 8-K 24190
2 EX-99.1 d100550dex991.htm EX-99.1 51254
6 GRAPHIC g100550g0225054917692.jpg GRAPHIC 3632
  Complete submission text file 0001193125-21-055874.txt   217907

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20210225.xsd EX-101.SCH 3087
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20210225_lab.xml EX-101.LAB 18907
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20210225_pre.xml EX-101.PRE 11874
7 EXTRACTED XBRL INSTANCE DOCUMENT d100550d8k_htm.xml XML 3509
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 21676681
SIC: 2834 Pharmaceutical Preparations